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ASSOCIATION OF FRAMINGHAM RISK SCORE WITH CHRONIC KIDNEY
DISEASE – INSIGHT FROM NATIONAL HEALTH AND NUTRITION
EXAMINATION SURVEY 2003-2006
Chien Yu Lina, Jou WeiLinaa
a
Department of Internal Medicine, En Chu Kong Hospital, Taipei County,
Taiwan
Background: The objective of this study was designed to illustrate the
association between cardiovascular risk factors and CKD.
Methods: Subjects aged between 30 and 74 who participated in the
National Health and Nutrition Examination Survey (2003-2006) were
included for analysis, and Framingham risk score was calculated.
Glomerular ﬁltration rate was estimated (eGFR) by the Modiﬁcation of Diet
in Renal Disease (MDRD) Equation, and CKD was deﬁned as eGFR less than
60 ml/min/1.73m2.
Results: A total of 2524 men (mean age: 51713) and 2516 women
(mean age: 50713) completed both cardiovascular risk assessment and
renal function evaluation. The proportion of Mexican Hispanic, other
Hispanic, whites, blacks, and other races was 20.4%, 3.1%, 51.9%, 20.4%, and
4.2%, respectively. The 10-year coronary risk, deﬁned as high (4¼20%),
intermediate (1020%), and low (o 10%) was assigned to 374 (14.8%), 654
( 25.9%), and 1496 (59.3%) male subjects, and to 44 (1.7%), 365 (14.5%), and
2107 (83.7%) female subjects. The crude prevalence of CKD was 5.7% in
men and 7.2% in women. The markers of renal function including serum
creatinine, estimate GFR, percentage of CKD, urine albumin/creatinine ratio
and percentage of microalbuminuria all correlated with the degree of
Framingham risk score. Male subjects in the high- and intermediate-CHD-
risk group was positively associated with the risk of microalbuminuria in
subjects with normal GFR ^ 90cc/min/1.73m2 (odds ratio:, 95% CI:, p o
0.001, and OR:, 95% CI:, p o 0.001) as compared to those in the low-CHD-
risk group. In the female, the odds ratio was (high risk vs. low risk, 95% CI:,
p o 0.001) and (intermediate risk vs. low risk: 95% CI:, p o 0.001). Male
subjects in the high- and intermediate-CHD-risk group was positively
associated y
Conclusion: The population-based cohort has demonstrated that
Framingham risk score could be used as a potential predictor not only for
future CHD but also for concurrent CKD.
http://dx.doi.org/10.1016/j.krcp.2012.04.466143
FINDING PHOSPHORUS CONTAINING ADDITIVES IN
MANUFACTURED FOODS
Lyn Lloyd, Lyn Gillanders
Auckland City Hospital, Auckland, New Zealand
Dietary phosphorous (P) intake is associated with an increased serum
phosphate level which is a risk factor for cardiovascular disease and
increased mortality for people with chronic kidney disease. Dietary
restriction of P is an important nutrition intervention as about 50% of daily
intake of P is from P–containing food additives. Educating patients on P
additives can effectively reduce serum P values over standard care.
Avoidance can be achieved by reading the ingredient list to check for over
20 P additives either by name or a number which is burdensome and
confusing. The purpose of this study was to search an existing NZ
Manufactured Foods Database (5126 manufactured foods available in NZ)
to obtain: 1. Listings of foods free from P additives; 2. Identiﬁcation of food
groups more likely to contain P additives; 3. Commonly used P additives
There were 1,920 foods (37%) that contained at least 1 P additive. The
most commonly used P additives were 450, 451, 322 and 1442.Food Group % Foods with at
least one additiveMost common
additive usedMeat and Poultry Products 76 450, 451
Fish and Seafood Products 39 450, 451
Yoghurt 59 1142, 341
Vegetable Products 25 450, 1414, 322
Snack Foods 68 322, 1442
Biscuits 61 322, 450Cakes, Buns, Pastries 86 450, 541, 1442
Breakfast Cereals 32 322, 101This reﬂects manufactured foods in NZ and it is likely that these results
could be generalized to countries with similar food patterns and supplies.
Quantitative data in manufactured foods is unlikely to be available to guide
patient choice so qualitative information of where to ﬁnd P additives can
be helpful.
http://dx.doi.org/10.1016/j.krcp.2012.04.467144
ASSOCIATION BETWEEN ALTERED TASTE PERCEOPTION AND
NUTRITIONAL OUTCOMES AMONG HEMODIALYSIS PATIENTS
Katherine Lynch, Rebecca Lynch, Gary Curhan
Steven BrunelliBeth Israel Deaconess Medical Center, Boston, MA.
Brigham and Women’s Hospital, Boston, MA
Taste impairment is prevalent among patients with end-stage renal
disease and may compromise nutritional status. There have been no
studies examining altered taste perception and nutritional outcomes. We
performed a post-hoc analysis of data from the HEMO Study (n¼1745).
Taste perception was assessed at baseline and then updated annually.
Time-updated linear and logistic regression models were used to examine
the nutritional impact of altered taste perception and to evaluate
predictors of altered taste perception.
At baseline, 34.6% reported altered taste perception, which was
associated with poorer nutritional indices. On longitudinal analysis, altered
taste perception was independently associated with a persistently greater
need for nutritional supplementation and subsequent reductions in serum
albumin (-0.03 g/dL; p¼0.02), serum creatinine (-0.22 mg/dL; p¼0.009),
normalized protein catabolic rate (-0.05; p o 0.001), protein intake (-
0.04¼ g/kg/day; p¼0.006), sodium intake (-90 mg/day; p¼0.02), and mid–
arm muscle circumference (-0.29 cm; p¼0.05).
Among prevalent hemodialysis patients, altered taste perception was
found to be associated with poorer indices of nutritional status at baseline
as well as subsequent decline in nutritional indices over time
http://dx.doi.org/10.1016/j.krcp.2012.04.468
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INCREASED PREVALENCE OF MALNUTRITION AND REDUCED LEAN BODY
MASS IN OVERWEIGHT/OBESE KIDNEY TRANSPLANT RECIPIENTS
Sylwia Ma"gorzewicz, Beata Czajka, Alicja De˛bska-Slizien,
Micha" Chmielewski, Juan Jesus Carrero, Boles"aw Rutkowski
Overweight and obesity are common in subjects after kidney
transplantation. On the other hand, features of malnutrition are also
frequently recognized in this group of patients. The aim of the study was to
evaluate the prevalence of both abnormalities in a cohort of stable kidney
recipients and to assess whether obesity precludes malnutrition in
transplanted patients. We also investigated associations between the
nutritional status, graft function and adipokines concentrations. The study
was performed in 80 prevalent kidney transplant patients and in a control
group which consisted of 23 healthy volunteers. Body composition (% of fat,
lean body mass (LBM), water content) was measured by multifrequency
bioelectrical impedance (Body Composition Manager). Nutritional status
was determined by a 7–point Subjective Global Assessment (SGA),
anthropometric measurements and s-albumin concentration. C–reactive
protein (CRP), Il–6 and plasminogen activator inhibitor–1 (PAI–1) were used
as markers of inﬂammatory status. Concentration of leptin, adiponectin and
visfatin were measured by ELISA. Results: Mean age was 52.4713.9 years
(45 men and 35 women). Diabetes mellitus was present in 29% (n¼23) of
them. Mean time after transplantation (transplantation vintage) was
82.5756.5 months (median¼73 months). Mean eGFR was 41.7714.9 ml/
min (4 points MDRD), BMI was 25.774.2. Overweight was present in 41%
of the patients and obesity in 14%. On the basis of SGA evaluation, signs of
